Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-10-01

AUTHORS

Stavroula Masouridi-Levrat, Eduardo Olavarria, Simona Iacobelli, Mahmoud Aljurf, Elena Morozova, Riitta Niittyvuopio, Henrik Sengeloev, Peter Reményi, Grzegorz Helbig, Paul Browne, Arnold Ganser, Arnon Nagler, John A. Snowden, Marie Robin, Jakob Passweg, Gwendolyn Van Gorkom, Hélène Labussière Wallet, Jennifer Hoek, Henric-Jan Blok, Theo De Witte, Nicolaus Kroeger, Patrick Hayden, Yves Chalandon, Ibrahim Yakoub Agha

ABSTRACT

Allogeneic hematopoietic cell transplantation (allo-HCT) remains a treatment option for patients with chronic myeloid leukemia (CML) who fail to respond to tyrosine kinase inhibitors (TKIs). While imatinib seems to have no adverse impact on outcomes after transplant, little is known on the effects of prior use of second-generation TKI (2GTKI). We present the results of a prospective non-interventional study performed by the EBMT on 383 consecutive CML patients previously treated with dasatinib or nilotinib undergoing allo-HCT from 2009 to 2013. The median age was 45 years (18–68). Disease status at transplant was CP1 in 139 patients (38%), AP or >CP1 in 163 (45%), and BC in 59 (16%). The choice of 2GTKI was: 40% dasatinib, 17% nilotinib, and 43% a sequential treatment of dasatinib and nilotinib with or without bosutinib/ponatinib. With a median follow-up of 37 months (1–77), 8% of patients developed either primary or secondary graft failure, 34% acute and 60% chronic GvHD. There were no differences in post-transplant complications between the three different 2GTKI subgroups. Non-relapse mortality was 18% and 24% at 12 months and at 5 years, respectively. Relapse incidence was 36%, overall survival 56% and relapse-free survival 40% at 5 years. No differences in post-transplant outcomes were found between the three different 2GTKI subgroups. This prospective study demonstrates the feasibility of allo-HCT in patients previously treated with 2GTKI with a post-transplant complications rate comparable to that of TKI-naive or imatinib-treated patients. More... »

PAGES

23-30

References to SciGraph publications

  • 2011-02-21. Imatinib is effective for prevention and improvement of fibrotic fasciitis as a manifestation of chronic GVHD in BONE MARROW TRANSPLANTATION
  • 2016-02-03. Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial in LEUKEMIA
  • 2011-10-10. Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis in BONE MARROW TRANSPLANTATION
  • 2015-03-23. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT) in BONE MARROW TRANSPLANTATION
  • 2005-07-11. Imatinib therapy prior to myeloablative allogeneic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2019-04-08. Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry in BONE MARROW TRANSPLANTATION
  • 2015-07-29. Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome in ANNALS OF HEMATOLOGY
  • 2015-11-17. Allogeneic transplantation for CML in the TKI era: striking the right balance in NATURE REVIEWS CLINICAL ONCOLOGY
  • 2008-07-03. Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive acute lymphoblastic leukemia in LEUKEMIA
  • 2016-08-29. Treatment and outcome of 2904 CML patients from the EUTOS population-based registry in LEUKEMIA
  • 2012-07-05. Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study in LEUKEMIA
  • Journal

    TITLE

    Bone Marrow Transplantation

    ISSUE

    1

    VOLUME

    57

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41409-021-01472-x

    DOI

    http://dx.doi.org/10.1038/s41409-021-01472-x

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1141548155

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/34599284


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dasatinib", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Graft vs Host Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Hematopoietic Stem Cell Transplantation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Imatinib Mesylate", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Protein Kinase Inhibitors", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.8591.5", 
              "name": [
                "Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Masouridi-Levrat", 
            "givenName": "Stavroula", 
            "id": "sg:person.0632154014.44", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632154014.44"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hammersmith Hospital, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.413629.b", 
              "name": [
                "Hammersmith Hospital, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Olavarria", 
            "givenName": "Eduardo", 
            "id": "sg:person.01171311241.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171311241.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University of Rome \u201cTor Vergata\u201d, Rome, Italy", 
              "id": "http://www.grid.ac/institutes/grid.6530.0", 
              "name": [
                "University of Rome \u201cTor Vergata\u201d, Rome, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Iacobelli", 
            "givenName": "Simona", 
            "id": "sg:person.01326154641.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326154641.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia", 
              "id": "http://www.grid.ac/institutes/grid.415310.2", 
              "name": [
                "King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Aljurf", 
            "givenName": "Mahmoud", 
            "id": "sg:person.01162416051.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162416051.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia", 
              "id": "http://www.grid.ac/institutes/grid.412460.5", 
              "name": [
                "First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Morozova", 
            "givenName": "Elena", 
            "id": "sg:person.0706577026.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706577026.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "HUCH Comprehensive Cancer Center, Helsinki, Finland", 
              "id": "http://www.grid.ac/institutes/grid.15485.3d", 
              "name": [
                "HUCH Comprehensive Cancer Center, Helsinki, Finland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Niittyvuopio", 
            "givenName": "Riitta", 
            "id": "sg:person.01241326272.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241326272.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Bone Marrow Transplant Unit L 4043, Copenhagen, Denmark", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Bone Marrow Transplant Unit L 4043, Copenhagen, Denmark"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sengeloev", 
            "givenName": "Henrik", 
            "id": "sg:person.0605240576.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605240576.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Budapest, Hungary", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "D\u00e9l-pesti Centrumk\u00f3rh\u00e1z, Budapest, Hungary"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rem\u00e9nyi", 
            "givenName": "Peter", 
            "id": "sg:person.01162522552.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162522552.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Silesian Medical Academy, Katowice, Poland", 
              "id": "http://www.grid.ac/institutes/grid.411728.9", 
              "name": [
                "Silesian Medical Academy, Katowice, Poland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Helbig", 
            "givenName": "Grzegorz", 
            "id": "sg:person.01123266524.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123266524.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hope Directorate, Dublin, Ireland", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Hope Directorate, Dublin, Ireland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Browne", 
            "givenName": "Paul", 
            "id": "sg:person.01025400226.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025400226.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hannover Medical School, Hannover, Germany", 
              "id": "http://www.grid.ac/institutes/grid.10423.34", 
              "name": [
                "Hannover Medical School, Hannover, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ganser", 
            "givenName": "Arnold", 
            "id": "sg:person.01225227464.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225227464.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Chaim Sheba Medical Center, Tel-Hashomer, Israel", 
              "id": "http://www.grid.ac/institutes/grid.413795.d", 
              "name": [
                "Chaim Sheba Medical Center, Tel-Hashomer, Israel"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nagler", 
            "givenName": "Arnon", 
            "id": "sg:person.0644252102.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644252102.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Sheffield Teaching Hospitals NHS Trust, Sheffield, UK", 
              "id": "http://www.grid.ac/institutes/grid.31410.37", 
              "name": [
                "Sheffield Teaching Hospitals NHS Trust, Sheffield, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Snowden", 
            "givenName": "John A.", 
            "id": "sg:person.012030144222.63", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012030144222.63"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hopital St. Louis, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.413328.f", 
              "name": [
                "Hopital St. Louis, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Robin", 
            "givenName": "Marie", 
            "id": "sg:person.01261354403.95", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261354403.95"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "University Hospital, Basel, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.410567.1", 
              "name": [
                "University Hospital, Basel, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Passweg", 
            "givenName": "Jakob", 
            "id": "sg:person.01114437057.45", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114437057.45"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.412966.e", 
              "name": [
                "Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Van Gorkom", 
            "givenName": "Gwendolyn", 
            "id": "sg:person.0743012266.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743012266.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "H\u00f4pital Lyon Sud, Hospices Civils de Lyon, Pierre B\u00e9nite, France", 
              "id": "http://www.grid.ac/institutes/grid.411430.3", 
              "name": [
                "H\u00f4pital Lyon Sud, Hospices Civils de Lyon, Pierre B\u00e9nite, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wallet", 
            "givenName": "H\u00e9l\u00e8ne Labussi\u00e8re", 
            "id": "sg:person.01145324444.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145324444.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "EBMT Data Office Leiden, Leiden, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.476306.0", 
              "name": [
                "EBMT Data Office Leiden, Leiden, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hoek", 
            "givenName": "Jennifer", 
            "id": "sg:person.01177572033.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177572033.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "EBMT Data Office Leiden, Leiden, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.476306.0", 
              "name": [
                "EBMT Data Office Leiden, Leiden, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Blok", 
            "givenName": "Henric-Jan", 
            "id": "sg:person.07544462214.69", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07544462214.69"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nijmegen Medical Centre, Radboud University, Nijmegen, Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5590.9", 
              "name": [
                "Nijmegen Medical Centre, Radboud University, Nijmegen, Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "De Witte", 
            "givenName": "Theo", 
            "id": "sg:person.015730551677.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015730551677.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany", 
              "id": "http://www.grid.ac/institutes/grid.13648.38", 
              "name": [
                "Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kroeger", 
            "givenName": "Nicolaus", 
            "id": "sg:person.01132525232.93", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132525232.93"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "St. James\u2019s Hospital, Dublin, Ireland", 
              "id": "http://www.grid.ac/institutes/grid.416409.e", 
              "name": [
                "St. James\u2019s Hospital, Dublin, Ireland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hayden", 
            "givenName": "Patrick", 
            "id": "sg:person.0662742343.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662742343.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland", 
              "id": "http://www.grid.ac/institutes/grid.8591.5", 
              "name": [
                "Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chalandon", 
            "givenName": "Yves", 
            "id": "sg:person.01203616663.55", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203616663.55"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France", 
              "id": "http://www.grid.ac/institutes/grid.503422.2", 
              "name": [
                "CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Agha", 
            "givenName": "Ibrahim Yakoub", 
            "id": "sg:person.011212135025.81", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011212135025.81"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/leu.2016.5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041273297", 
              "https://doi.org/10.1038/leu.2016.5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bmt.2015.52", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003530776", 
              "https://doi.org/10.1038/bmt.2015.52"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00277-015-2457-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012076774", 
              "https://doi.org/10.1007/s00277-015-2457-1"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2016.246", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041008223", 
              "https://doi.org/10.1038/leu.2016.246"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bmt.1705087", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037387036", 
              "https://doi.org/10.1038/sj.bmt.1705087"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bmt.2011.10", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022514393", 
              "https://doi.org/10.1038/bmt.2011.10"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2008.160", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051243050", 
              "https://doi.org/10.1038/leu.2008.160"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/s41409-019-0513-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1113300724", 
              "https://doi.org/10.1038/s41409-019-0513-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrclinonc.2015.193", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031502952", 
              "https://doi.org/10.1038/nrclinonc.2015.193"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/leu.2012.181", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028369333", 
              "https://doi.org/10.1038/leu.2012.181"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bmt.2011.194", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001069642", 
              "https://doi.org/10.1038/bmt.2011.194"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2021-10-01", 
        "datePublishedReg": "2021-10-01", 
        "description": "Allogeneic hematopoietic cell transplantation (allo-HCT) remains a treatment option for patients with chronic myeloid leukemia (CML) who fail to respond to tyrosine kinase inhibitors (TKIs). While imatinib seems to have no adverse impact on outcomes after transplant, little is known on the effects of prior use of second-generation TKI (2GTKI). We present the results of a prospective non-interventional study performed by the EBMT on 383 consecutive CML patients previously treated with dasatinib or nilotinib undergoing allo-HCT from 2009 to 2013. The median age was 45 years (18\u201368). Disease status at transplant was CP1 in 139 patients (38%), AP or >CP1 in 163 (45%), and BC in 59 (16%). The choice of 2GTKI was: 40% dasatinib, 17% nilotinib, and 43% a sequential treatment of dasatinib and nilotinib with or without bosutinib/ponatinib. With a median follow-up of 37 months (1\u201377), 8% of patients developed either primary or secondary graft failure, 34% acute and 60% chronic GvHD. There were no differences in post-transplant complications between the three different 2GTKI subgroups. Non-relapse mortality was 18% and 24% at 12 months and at 5 years, respectively. Relapse incidence was 36%, overall survival 56% and relapse-free survival 40% at 5 years. No differences in post-transplant outcomes were found between the three different 2GTKI subgroups. This prospective study demonstrates the feasibility of allo-HCT in patients previously treated with 2GTKI with a post-transplant complications rate comparable to that of TKI-naive or imatinib-treated patients.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41409-021-01472-x", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1096890", 
            "issn": [
              "0268-3369", 
              "1476-5365"
            ], 
            "name": "Bone Marrow Transplantation", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "57"
          }
        ], 
        "keywords": [
          "tyrosine kinase inhibitors", 
          "second-generation tyrosine kinase inhibitors", 
          "prospective non-interventional study", 
          "hematopoietic cell transplantation", 
          "non-interventional study", 
          "chronic myeloid leukemia", 
          "allo-HCT", 
          "cell transplantation", 
          "Chronic Malignancies Working Party", 
          "allogeneic hematopoietic cell transplantation", 
          "chronic myeloid leukemia patients", 
          "kinase inhibitors", 
          "consecutive CML patients", 
          "post-transplant complications", 
          "non-relapse mortality", 
          "secondary graft failure", 
          "post-transplant outcomes", 
          "imatinib-treated patients", 
          "myeloid leukemia patients", 
          "chronic GVHD", 
          "relapse incidence", 
          "graft failure", 
          "complication rate", 
          "median age", 
          "prospective study", 
          "treatment options", 
          "CML patients", 
          "myeloid leukemia", 
          "leukemia patients", 
          "patients", 
          "disease status", 
          "prior use", 
          "nilotinib", 
          "dasatinib", 
          "transplantation", 
          "transplant", 
          "outcomes", 
          "EBMT", 
          "sequential treatment", 
          "Working Party", 
          "months", 
          "subgroups", 
          "inhibitors", 
          "years", 
          "GVHD", 
          "complications", 
          "imatinib", 
          "ponatinib", 
          "leukemia", 
          "mortality", 
          "incidence", 
          "study", 
          "age", 
          "treatment", 
          "differences", 
          "toxicity", 
          "status", 
          "failure", 
          "options", 
          "adverse impact", 
          "AP", 
          "rate", 
          "effect", 
          "use", 
          "feasibility", 
          "impact", 
          "choice", 
          "results", 
          "CP1", 
          "BC", 
          "parties"
        ], 
        "name": "Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT", 
        "pagination": "23-30", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1141548155"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41409-021-01472-x"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "34599284"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41409-021-01472-x", 
          "https://app.dimensions.ai/details/publication/pub.1141548155"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T21:08", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_916.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41409-021-01472-x"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01472-x'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01472-x'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01472-x'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41409-021-01472-x'


     

    This table displays all metadata directly associated to this object as RDF triples.

    434 TRIPLES      21 PREDICATES      116 URIs      97 LITERALS      16 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41409-021-01472-x schema:about N082c97427a544d5a90b7261194a16f30
    2 N08e882f181c74be891e0c384ee0ba099
    3 N4ed68d97b3c24a34a554a211aadd3d32
    4 N76c305035aee457281cedbd1e2a6d975
    5 N8461ec2c6fd74c5f84ae639cf50d0aab
    6 N9ce46a4e6ee1407ba644a947f3a446c9
    7 Na5e48988f8c4475ba3a6efdabcd14cdb
    8 Nc19e08c0750549d992bd83f71f5fe91b
    9 Nea21b9ebcceb4d22a59eac9745fed7b9
    10 anzsrc-for:11
    11 anzsrc-for:1112
    12 schema:author N49388957df1c450eaec8082687a6577c
    13 schema:citation sg:pub.10.1007/s00277-015-2457-1
    14 sg:pub.10.1038/bmt.2011.10
    15 sg:pub.10.1038/bmt.2011.194
    16 sg:pub.10.1038/bmt.2015.52
    17 sg:pub.10.1038/leu.2008.160
    18 sg:pub.10.1038/leu.2012.181
    19 sg:pub.10.1038/leu.2016.246
    20 sg:pub.10.1038/leu.2016.5
    21 sg:pub.10.1038/nrclinonc.2015.193
    22 sg:pub.10.1038/s41409-019-0513-5
    23 sg:pub.10.1038/sj.bmt.1705087
    24 schema:datePublished 2021-10-01
    25 schema:datePublishedReg 2021-10-01
    26 schema:description Allogeneic hematopoietic cell transplantation (allo-HCT) remains a treatment option for patients with chronic myeloid leukemia (CML) who fail to respond to tyrosine kinase inhibitors (TKIs). While imatinib seems to have no adverse impact on outcomes after transplant, little is known on the effects of prior use of second-generation TKI (2GTKI). We present the results of a prospective non-interventional study performed by the EBMT on 383 consecutive CML patients previously treated with dasatinib or nilotinib undergoing allo-HCT from 2009 to 2013. The median age was 45 years (18–68). Disease status at transplant was CP1 in 139 patients (38%), AP or >CP1 in 163 (45%), and BC in 59 (16%). The choice of 2GTKI was: 40% dasatinib, 17% nilotinib, and 43% a sequential treatment of dasatinib and nilotinib with or without bosutinib/ponatinib. With a median follow-up of 37 months (1–77), 8% of patients developed either primary or secondary graft failure, 34% acute and 60% chronic GvHD. There were no differences in post-transplant complications between the three different 2GTKI subgroups. Non-relapse mortality was 18% and 24% at 12 months and at 5 years, respectively. Relapse incidence was 36%, overall survival 56% and relapse-free survival 40% at 5 years. No differences in post-transplant outcomes were found between the three different 2GTKI subgroups. This prospective study demonstrates the feasibility of allo-HCT in patients previously treated with 2GTKI with a post-transplant complications rate comparable to that of TKI-naive or imatinib-treated patients.
    27 schema:genre article
    28 schema:isAccessibleForFree true
    29 schema:isPartOf N18608e6af62245fc8a824652f023e3c7
    30 Ne0e3081e73294221a4145c74eb70f53a
    31 sg:journal.1096890
    32 schema:keywords AP
    33 BC
    34 CML patients
    35 CP1
    36 Chronic Malignancies Working Party
    37 EBMT
    38 GVHD
    39 Working Party
    40 adverse impact
    41 age
    42 allo-HCT
    43 allogeneic hematopoietic cell transplantation
    44 cell transplantation
    45 choice
    46 chronic GVHD
    47 chronic myeloid leukemia
    48 chronic myeloid leukemia patients
    49 complication rate
    50 complications
    51 consecutive CML patients
    52 dasatinib
    53 differences
    54 disease status
    55 effect
    56 failure
    57 feasibility
    58 graft failure
    59 hematopoietic cell transplantation
    60 imatinib
    61 imatinib-treated patients
    62 impact
    63 incidence
    64 inhibitors
    65 kinase inhibitors
    66 leukemia
    67 leukemia patients
    68 median age
    69 months
    70 mortality
    71 myeloid leukemia
    72 myeloid leukemia patients
    73 nilotinib
    74 non-interventional study
    75 non-relapse mortality
    76 options
    77 outcomes
    78 parties
    79 patients
    80 ponatinib
    81 post-transplant complications
    82 post-transplant outcomes
    83 prior use
    84 prospective non-interventional study
    85 prospective study
    86 rate
    87 relapse incidence
    88 results
    89 second-generation tyrosine kinase inhibitors
    90 secondary graft failure
    91 sequential treatment
    92 status
    93 study
    94 subgroups
    95 toxicity
    96 transplant
    97 transplantation
    98 treatment
    99 treatment options
    100 tyrosine kinase inhibitors
    101 use
    102 years
    103 schema:name Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT
    104 schema:pagination 23-30
    105 schema:productId N3aea2c644d8e4ccca428352c0cdb0bb3
    106 N6a99088f36bf441cafc9ee6350de17c4
    107 Nc6c8bbc5a2e949e0bddb26229fd6be95
    108 schema:sameAs https://app.dimensions.ai/details/publication/pub.1141548155
    109 https://doi.org/10.1038/s41409-021-01472-x
    110 schema:sdDatePublished 2022-11-24T21:08
    111 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    112 schema:sdPublisher Ndc4ca63aa86f408dab54cb32cdd8e52c
    113 schema:url https://doi.org/10.1038/s41409-021-01472-x
    114 sgo:license sg:explorer/license/
    115 sgo:sdDataset articles
    116 rdf:type schema:ScholarlyArticle
    117 N00677b34509546ce896ccd27b00993c2 rdf:first sg:person.0743012266.18
    118 rdf:rest N8547b12b9dbb4df9ae1b39e6e084f903
    119 N03195676213e4104a814878680e33f06 rdf:first sg:person.0706577026.12
    120 rdf:rest N1487e9d9f9674f93bc8ba5400a2107d3
    121 N082c97427a544d5a90b7261194a16f30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    122 schema:name Prospective Studies
    123 rdf:type schema:DefinedTerm
    124 N08e882f181c74be891e0c384ee0ba099 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    125 schema:name Graft vs Host Disease
    126 rdf:type schema:DefinedTerm
    127 N1487e9d9f9674f93bc8ba5400a2107d3 rdf:first sg:person.01241326272.90
    128 rdf:rest N42577f28e5e64c079203f4fb5f8d9ab6
    129 N170e098bce114829b75627e5578738be rdf:first sg:person.01225227464.09
    130 rdf:rest Ne9ef5aa5ecca469f94ac1846091b30ee
    131 N18608e6af62245fc8a824652f023e3c7 schema:issueNumber 1
    132 rdf:type schema:PublicationIssue
    133 N1f1b55668702420b97810166cf54a150 rdf:first sg:person.012030144222.63
    134 rdf:rest N38a0b127114d415eadc2b452fdd0b1a1
    135 N22d1e514ea3c4489a37150a6a3daff23 rdf:first sg:person.01326154641.79
    136 rdf:rest N767d0763db864e9580c3bf080d9682cd
    137 N25a38aaac1ef49fe866a4f4bcf570c98 rdf:first sg:person.01171311241.36
    138 rdf:rest N22d1e514ea3c4489a37150a6a3daff23
    139 N262bb049571e45ab8d689c3da4467a4b rdf:first sg:person.01123266524.90
    140 rdf:rest N959124665d8a4a26a61fcff8e414a040
    141 N38a0b127114d415eadc2b452fdd0b1a1 rdf:first sg:person.01261354403.95
    142 rdf:rest Na4181c379cc7440698a97e3b07135256
    143 N3aea2c644d8e4ccca428352c0cdb0bb3 schema:name dimensions_id
    144 schema:value pub.1141548155
    145 rdf:type schema:PropertyValue
    146 N42577f28e5e64c079203f4fb5f8d9ab6 rdf:first sg:person.0605240576.08
    147 rdf:rest N9ba55239e46946ceb8e3f7d389e85fbb
    148 N49388957df1c450eaec8082687a6577c rdf:first sg:person.0632154014.44
    149 rdf:rest N25a38aaac1ef49fe866a4f4bcf570c98
    150 N4ed68d97b3c24a34a554a211aadd3d32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Hematopoietic Stem Cell Transplantation
    152 rdf:type schema:DefinedTerm
    153 N589aa1821d914c9fa56be145282aa5ee rdf:first sg:person.01132525232.93
    154 rdf:rest Ne9214e0ea937411cb671cdd59fcba8c7
    155 N6a99088f36bf441cafc9ee6350de17c4 schema:name doi
    156 schema:value 10.1038/s41409-021-01472-x
    157 rdf:type schema:PropertyValue
    158 N72722bdffafd40cb93b9949125836399 rdf:first sg:person.07544462214.69
    159 rdf:rest Nc5b5bde0680d4780b0c20c3c2c483f04
    160 N767d0763db864e9580c3bf080d9682cd rdf:first sg:person.01162416051.35
    161 rdf:rest N03195676213e4104a814878680e33f06
    162 N76c305035aee457281cedbd1e2a6d975 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    164 rdf:type schema:DefinedTerm
    165 N8461ec2c6fd74c5f84ae639cf50d0aab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Imatinib Mesylate
    167 rdf:type schema:DefinedTerm
    168 N8547b12b9dbb4df9ae1b39e6e084f903 rdf:first sg:person.01145324444.34
    169 rdf:rest Nf29e4c01f4b14591bb8cd85d54ea0ea6
    170 N959124665d8a4a26a61fcff8e414a040 rdf:first sg:person.01025400226.77
    171 rdf:rest N170e098bce114829b75627e5578738be
    172 N9707f9b541904fb8b59477941513af9c rdf:first sg:person.01203616663.55
    173 rdf:rest N9a6d5b33fc544837b04d03f232a5ae09
    174 N9a6d5b33fc544837b04d03f232a5ae09 rdf:first sg:person.011212135025.81
    175 rdf:rest rdf:nil
    176 N9ba55239e46946ceb8e3f7d389e85fbb rdf:first sg:person.01162522552.34
    177 rdf:rest N262bb049571e45ab8d689c3da4467a4b
    178 N9ce46a4e6ee1407ba644a947f3a446c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Dasatinib
    180 rdf:type schema:DefinedTerm
    181 Na4181c379cc7440698a97e3b07135256 rdf:first sg:person.01114437057.45
    182 rdf:rest N00677b34509546ce896ccd27b00993c2
    183 Na5e48988f8c4475ba3a6efdabcd14cdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    184 schema:name Middle Aged
    185 rdf:type schema:DefinedTerm
    186 Nc19e08c0750549d992bd83f71f5fe91b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Humans
    188 rdf:type schema:DefinedTerm
    189 Nc5b5bde0680d4780b0c20c3c2c483f04 rdf:first sg:person.015730551677.08
    190 rdf:rest N589aa1821d914c9fa56be145282aa5ee
    191 Nc6c8bbc5a2e949e0bddb26229fd6be95 schema:name pubmed_id
    192 schema:value 34599284
    193 rdf:type schema:PropertyValue
    194 Ndc4ca63aa86f408dab54cb32cdd8e52c schema:name Springer Nature - SN SciGraph project
    195 rdf:type schema:Organization
    196 Ne0e3081e73294221a4145c74eb70f53a schema:volumeNumber 57
    197 rdf:type schema:PublicationVolume
    198 Ne9214e0ea937411cb671cdd59fcba8c7 rdf:first sg:person.0662742343.33
    199 rdf:rest N9707f9b541904fb8b59477941513af9c
    200 Ne9ef5aa5ecca469f94ac1846091b30ee rdf:first sg:person.0644252102.00
    201 rdf:rest N1f1b55668702420b97810166cf54a150
    202 Nea21b9ebcceb4d22a59eac9745fed7b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    203 schema:name Protein Kinase Inhibitors
    204 rdf:type schema:DefinedTerm
    205 Nf29e4c01f4b14591bb8cd85d54ea0ea6 rdf:first sg:person.01177572033.08
    206 rdf:rest N72722bdffafd40cb93b9949125836399
    207 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    208 schema:name Medical and Health Sciences
    209 rdf:type schema:DefinedTerm
    210 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    211 schema:name Oncology and Carcinogenesis
    212 rdf:type schema:DefinedTerm
    213 sg:journal.1096890 schema:issn 0268-3369
    214 1476-5365
    215 schema:name Bone Marrow Transplantation
    216 schema:publisher Springer Nature
    217 rdf:type schema:Periodical
    218 sg:person.01025400226.77 schema:affiliation grid-institutes:None
    219 schema:familyName Browne
    220 schema:givenName Paul
    221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025400226.77
    222 rdf:type schema:Person
    223 sg:person.01114437057.45 schema:affiliation grid-institutes:grid.410567.1
    224 schema:familyName Passweg
    225 schema:givenName Jakob
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114437057.45
    227 rdf:type schema:Person
    228 sg:person.011212135025.81 schema:affiliation grid-institutes:grid.503422.2
    229 schema:familyName Agha
    230 schema:givenName Ibrahim Yakoub
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011212135025.81
    232 rdf:type schema:Person
    233 sg:person.01123266524.90 schema:affiliation grid-institutes:grid.411728.9
    234 schema:familyName Helbig
    235 schema:givenName Grzegorz
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01123266524.90
    237 rdf:type schema:Person
    238 sg:person.01132525232.93 schema:affiliation grid-institutes:grid.13648.38
    239 schema:familyName Kroeger
    240 schema:givenName Nicolaus
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132525232.93
    242 rdf:type schema:Person
    243 sg:person.01145324444.34 schema:affiliation grid-institutes:grid.411430.3
    244 schema:familyName Wallet
    245 schema:givenName Hélène Labussière
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145324444.34
    247 rdf:type schema:Person
    248 sg:person.01162416051.35 schema:affiliation grid-institutes:grid.415310.2
    249 schema:familyName Aljurf
    250 schema:givenName Mahmoud
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162416051.35
    252 rdf:type schema:Person
    253 sg:person.01162522552.34 schema:affiliation grid-institutes:None
    254 schema:familyName Reményi
    255 schema:givenName Peter
    256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01162522552.34
    257 rdf:type schema:Person
    258 sg:person.01171311241.36 schema:affiliation grid-institutes:grid.413629.b
    259 schema:familyName Olavarria
    260 schema:givenName Eduardo
    261 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171311241.36
    262 rdf:type schema:Person
    263 sg:person.01177572033.08 schema:affiliation grid-institutes:grid.476306.0
    264 schema:familyName Hoek
    265 schema:givenName Jennifer
    266 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177572033.08
    267 rdf:type schema:Person
    268 sg:person.012030144222.63 schema:affiliation grid-institutes:grid.31410.37
    269 schema:familyName Snowden
    270 schema:givenName John A.
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012030144222.63
    272 rdf:type schema:Person
    273 sg:person.01203616663.55 schema:affiliation grid-institutes:grid.8591.5
    274 schema:familyName Chalandon
    275 schema:givenName Yves
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203616663.55
    277 rdf:type schema:Person
    278 sg:person.01225227464.09 schema:affiliation grid-institutes:grid.10423.34
    279 schema:familyName Ganser
    280 schema:givenName Arnold
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225227464.09
    282 rdf:type schema:Person
    283 sg:person.01241326272.90 schema:affiliation grid-institutes:grid.15485.3d
    284 schema:familyName Niittyvuopio
    285 schema:givenName Riitta
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241326272.90
    287 rdf:type schema:Person
    288 sg:person.01261354403.95 schema:affiliation grid-institutes:grid.413328.f
    289 schema:familyName Robin
    290 schema:givenName Marie
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261354403.95
    292 rdf:type schema:Person
    293 sg:person.01326154641.79 schema:affiliation grid-institutes:grid.6530.0
    294 schema:familyName Iacobelli
    295 schema:givenName Simona
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326154641.79
    297 rdf:type schema:Person
    298 sg:person.015730551677.08 schema:affiliation grid-institutes:grid.5590.9
    299 schema:familyName De Witte
    300 schema:givenName Theo
    301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015730551677.08
    302 rdf:type schema:Person
    303 sg:person.0605240576.08 schema:affiliation grid-institutes:None
    304 schema:familyName Sengeloev
    305 schema:givenName Henrik
    306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0605240576.08
    307 rdf:type schema:Person
    308 sg:person.0632154014.44 schema:affiliation grid-institutes:grid.8591.5
    309 schema:familyName Masouridi-Levrat
    310 schema:givenName Stavroula
    311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632154014.44
    312 rdf:type schema:Person
    313 sg:person.0644252102.00 schema:affiliation grid-institutes:grid.413795.d
    314 schema:familyName Nagler
    315 schema:givenName Arnon
    316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0644252102.00
    317 rdf:type schema:Person
    318 sg:person.0662742343.33 schema:affiliation grid-institutes:grid.416409.e
    319 schema:familyName Hayden
    320 schema:givenName Patrick
    321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0662742343.33
    322 rdf:type schema:Person
    323 sg:person.0706577026.12 schema:affiliation grid-institutes:grid.412460.5
    324 schema:familyName Morozova
    325 schema:givenName Elena
    326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706577026.12
    327 rdf:type schema:Person
    328 sg:person.0743012266.18 schema:affiliation grid-institutes:grid.412966.e
    329 schema:familyName Van Gorkom
    330 schema:givenName Gwendolyn
    331 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0743012266.18
    332 rdf:type schema:Person
    333 sg:person.07544462214.69 schema:affiliation grid-institutes:grid.476306.0
    334 schema:familyName Blok
    335 schema:givenName Henric-Jan
    336 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07544462214.69
    337 rdf:type schema:Person
    338 sg:pub.10.1007/s00277-015-2457-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012076774
    339 https://doi.org/10.1007/s00277-015-2457-1
    340 rdf:type schema:CreativeWork
    341 sg:pub.10.1038/bmt.2011.10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022514393
    342 https://doi.org/10.1038/bmt.2011.10
    343 rdf:type schema:CreativeWork
    344 sg:pub.10.1038/bmt.2011.194 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001069642
    345 https://doi.org/10.1038/bmt.2011.194
    346 rdf:type schema:CreativeWork
    347 sg:pub.10.1038/bmt.2015.52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003530776
    348 https://doi.org/10.1038/bmt.2015.52
    349 rdf:type schema:CreativeWork
    350 sg:pub.10.1038/leu.2008.160 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051243050
    351 https://doi.org/10.1038/leu.2008.160
    352 rdf:type schema:CreativeWork
    353 sg:pub.10.1038/leu.2012.181 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028369333
    354 https://doi.org/10.1038/leu.2012.181
    355 rdf:type schema:CreativeWork
    356 sg:pub.10.1038/leu.2016.246 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041008223
    357 https://doi.org/10.1038/leu.2016.246
    358 rdf:type schema:CreativeWork
    359 sg:pub.10.1038/leu.2016.5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041273297
    360 https://doi.org/10.1038/leu.2016.5
    361 rdf:type schema:CreativeWork
    362 sg:pub.10.1038/nrclinonc.2015.193 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031502952
    363 https://doi.org/10.1038/nrclinonc.2015.193
    364 rdf:type schema:CreativeWork
    365 sg:pub.10.1038/s41409-019-0513-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113300724
    366 https://doi.org/10.1038/s41409-019-0513-5
    367 rdf:type schema:CreativeWork
    368 sg:pub.10.1038/sj.bmt.1705087 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037387036
    369 https://doi.org/10.1038/sj.bmt.1705087
    370 rdf:type schema:CreativeWork
    371 grid-institutes:None schema:alternateName Bone Marrow Transplant Unit L 4043, Copenhagen, Denmark
    372 Dél-pesti Centrumkórház, Budapest, Hungary
    373 Hope Directorate, Dublin, Ireland
    374 schema:name Bone Marrow Transplant Unit L 4043, Copenhagen, Denmark
    375 Dél-pesti Centrumkórház, Budapest, Hungary
    376 Hope Directorate, Dublin, Ireland
    377 rdf:type schema:Organization
    378 grid-institutes:grid.10423.34 schema:alternateName Hannover Medical School, Hannover, Germany
    379 schema:name Hannover Medical School, Hannover, Germany
    380 rdf:type schema:Organization
    381 grid-institutes:grid.13648.38 schema:alternateName Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    382 schema:name Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany
    383 rdf:type schema:Organization
    384 grid-institutes:grid.15485.3d schema:alternateName HUCH Comprehensive Cancer Center, Helsinki, Finland
    385 schema:name HUCH Comprehensive Cancer Center, Helsinki, Finland
    386 rdf:type schema:Organization
    387 grid-institutes:grid.31410.37 schema:alternateName Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
    388 schema:name Sheffield Teaching Hospitals NHS Trust, Sheffield, UK
    389 rdf:type schema:Organization
    390 grid-institutes:grid.410567.1 schema:alternateName University Hospital, Basel, Switzerland
    391 schema:name University Hospital, Basel, Switzerland
    392 rdf:type schema:Organization
    393 grid-institutes:grid.411430.3 schema:alternateName Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France
    394 schema:name Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France
    395 rdf:type schema:Organization
    396 grid-institutes:grid.411728.9 schema:alternateName Silesian Medical Academy, Katowice, Poland
    397 schema:name Silesian Medical Academy, Katowice, Poland
    398 rdf:type schema:Organization
    399 grid-institutes:grid.412460.5 schema:alternateName First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia
    400 schema:name First Pavlov State Medical University of St. Petersburg, St. Petersburg, Russia
    401 rdf:type schema:Organization
    402 grid-institutes:grid.412966.e schema:alternateName Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
    403 schema:name Department of Internal Medicine, Division of Hematology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands
    404 rdf:type schema:Organization
    405 grid-institutes:grid.413328.f schema:alternateName Hopital St. Louis, Paris, France
    406 schema:name Hopital St. Louis, Paris, France
    407 rdf:type schema:Organization
    408 grid-institutes:grid.413629.b schema:alternateName Hammersmith Hospital, London, UK
    409 schema:name Hammersmith Hospital, London, UK
    410 rdf:type schema:Organization
    411 grid-institutes:grid.413795.d schema:alternateName Chaim Sheba Medical Center, Tel-Hashomer, Israel
    412 schema:name Chaim Sheba Medical Center, Tel-Hashomer, Israel
    413 rdf:type schema:Organization
    414 grid-institutes:grid.415310.2 schema:alternateName King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
    415 schema:name King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
    416 rdf:type schema:Organization
    417 grid-institutes:grid.416409.e schema:alternateName St. James’s Hospital, Dublin, Ireland
    418 schema:name St. James’s Hospital, Dublin, Ireland
    419 rdf:type schema:Organization
    420 grid-institutes:grid.476306.0 schema:alternateName EBMT Data Office Leiden, Leiden, The Netherlands
    421 schema:name EBMT Data Office Leiden, Leiden, The Netherlands
    422 rdf:type schema:Organization
    423 grid-institutes:grid.503422.2 schema:alternateName CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France
    424 schema:name CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, Lille, France
    425 rdf:type schema:Organization
    426 grid-institutes:grid.5590.9 schema:alternateName Nijmegen Medical Centre, Radboud University, Nijmegen, Netherlands
    427 schema:name Nijmegen Medical Centre, Radboud University, Nijmegen, Netherlands
    428 rdf:type schema:Organization
    429 grid-institutes:grid.6530.0 schema:alternateName University of Rome “Tor Vergata”, Rome, Italy
    430 schema:name University of Rome “Tor Vergata”, Rome, Italy
    431 rdf:type schema:Organization
    432 grid-institutes:grid.8591.5 schema:alternateName Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland
    433 schema:name Hematology Division and Faculty of Medicine, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland
    434 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...